C. Fonatsch
About
In The Last Decade
C. Fonatsch
15 papers receiving 391 citations
Peers
Comparison fields: 5 of 42
- Hematology 213
- Molecular Biology 207
- Genetics 97
- Public Health, Environmental and Occupational Health 74
- Oncology 64
Countries citing papers authored by C. Fonatsch
This map shows the geographic impact of C. Fonatsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Fonatsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Fonatsch more than expected).
Fields of papers citing papers by C. Fonatsch
This network shows the impact of papers produced by C. Fonatsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Fonatsch. The network helps show where C. Fonatsch may publish in the future.
Co-authorship network of co-authors of C. Fonatsch
This figure shows the co-authorship network connecting the top 25 collaborators of C. Fonatsch. A scholar is included among the top collaborators of C. Fonatsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Fonatsch. C. Fonatsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 7 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | Characterization of the continuous cell line HepT1 derived from a human hepatoblastoma. | 62 |
| 7 | De novo AML with dysplastic hematopoiesis: cytogenetic and prognostic significance. | 54 |
| 8 | Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor. | 102 |
| 9 | G-CSF in the long-term treatment of cyclic neutropenia and chronic idiopathic neutropenia in adult patients. | 9 |
| 10 | Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system. | 65 |
| 11 | Translocation t(1;22) mimicking t(1;19) in a child with acute lymphoblastic leukemia as revealed by chromosome painting. | 9 |
| 12 | [Comparison of flow cytometric, static cytometry and tumor cytogenetic investigation results human renal cell carcinomas]. | 3 |
| 13 | 3 | |
| 14 | [Primary (essential) thrombocythemia. Clinical findings, course and therapy in 26 patients]. | 1 |
| 15 | 67 | |
| 16 | 10 | |
| 17 | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.